SECUREKLOUD TECHNOLOGIES LIMITED

rs,

ion or opinions contained herein. None of the Company nor any of its respective affiliates, advisers, or representatives, shall have any liability whatsoever (in negligence or otherwise) for any loss h

10x

on Platform: Highly automated, fully secure, and compliant cloud platform-as-a-service Enabling 10x faster cloud deployment. Powering Enterprise Blockchain Transformation: Plug and play blockchain

INR 10,655 lakh

nd Confidential. © 2023 SecureKloud Technologies Ltd. Financial Highlights - Q4 FY23  Revenue of INR 10,655 lakhs  Healthcare and Life Science revenue of INR 7,470 lakhs for the quarter, growth 15.2%  Informa

INR 7,470 lakh

ncial Highlights - Q4 FY23  Revenue of INR 10,655 lakhs  Healthcare and Life Science revenue of INR 7,470 lakhs for the quarter, growth 15.2%  Information, Communication & Technology revenue of INR 3,185 lakh

15.2%

INR 10,655 lakhs  Healthcare and Life Science revenue of INR 7,470 lakhs for the quarter, growth 15.2%  Information, Communication & Technology revenue of INR 3,185 lakhs for the quarter, growth of 10

INR 3,185 lakh

INR 7,470 lakhs for the quarter, growth 15.2%  Information, Communication & Technology revenue of INR 3,185 lakhs for the quarter, growth of 10.8%  R&D spends of INR 1,376 lakhs for the quarter  Recurring rev

10.8%

2%  Information, Communication & Technology revenue of INR 3,185 lakhs for the quarter, growth of 10.8%  R&D spends of INR 1,376 lakhs for the quarter  Recurring revenue at 40.3% driven by Managed Se

INR 1,376 lakh

unication & Technology revenue of INR 3,185 lakhs for the quarter, growth of 10.8%  R&D spends of INR 1,376 lakhs for the quarter  Recurring revenue at 40.3% driven by Managed Services  One time cost relating

40.3%

e quarter, growth of 10.8%  R&D spends of INR 1,376 lakhs for the quarter  Recurring revenue at 40.3% driven by Managed Services  One time cost relating to contingent consideration provided during th

INR 492 lakh

Managed Services  One time cost relating to contingent consideration provided during the quarter INR 492 lakhs Proprietary and Confidential. © 2023 SecureKloud Technologies Ltd. Financial Highlights – FY23

INR 45,844 lakh

y and Confidential. © 2023 SecureKloud Technologies Ltd. Financial Highlights – FY23  Revenue of INR 45,844 lakhs; growth of 20.8% YoY  Healthcare and Life Science revenue of INR 34,247 lakhs; growth of 28.8% Y

20.8%

ecureKloud Technologies Ltd. Financial Highlights – FY23  Revenue of INR 45,844 lakhs; growth of 20.8% YoY  Healthcare and Life Science revenue of INR 34,247 lakhs; growth of 28.8% YoY.  Information

Now Data Collaboration is made easy

1

Platform

1

Blockchain Transformation

1

Now Data Collaboration is made easy

Powering seamless data sharing and collaboration while maintaining full control of privacy in a multi-tenant environment Highly Automated AI powered & Data Analytics Platform: Transforming data into actionable insights while enabling faster insight- driven decision-making Cloud Foundation

Platform

Highly automated, fully secure, and compliant cloud platform-as-a-service Enabling 10x faster cloud deployment. Powering Enterprise

Blockchain Transformation

Plug and play blockchains effortlessly while focused on providing better prospects for data security and governance No more paper documents: Empowering businesses with easy data extraction and digitization. AI/ML based self-learning product purpose-built to unlock siloed data across multiple documents The Arc of Transformation Proprietary and Confidential. © 2022 SecureKloud Technologies Ltd. Proprietary and Confidential. © 2023 SecureKloud Technologies Ltd. New Solutions to Accelerate Innovation - Metaverse We challenge ourselves every day, to deliver excellence for our customers across all industries Strategic Partnerships $996B TAM for Global Metaverse $22.79B 2022 Source: GlobalData $996B 2030 Proprietary and Confidential. © 2023 SecureKloud Technologies Ltd. Business Highlights  Added 4 new customer logos in Healthcare and Life Science segment  Partnered with a leading oncology company to build and deploy its enterprise cloud foundation platform in a DevOps environment.  Signed